Clinical Trial Update: Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating pacritinib in combination with chemotherapy for adults with acute myeloid leukemia, including FLT3-mutant AML; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Pacritinib (pacritinib)

Snippet

Sponsor: Bhavana Bhatnagar | Conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED